EMA & Biosimilar Update: Trends from marketing authorisation applications, scientific advice procedures and policies – Peter Richardson, EBG Biosimilars 2015, London (PPT)

24 April 2015

Scientific advice for continuous innovation in known… 5 May 2022 Open
Biosimilars Market Review 2023 18 September 2023 The purpose of this Market Review is to provide a…
EU pharmaceutical legislation reform critical to sustain… 6 October 2022 The EU plans to update its 20-year-old pharmaceutical legislation early…
The European Commission needs to prioritise equitable access… 25 January 2022 Over 15 years ago, the world’s first biosimilar was launched.…